Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.

Kidney transplant recipients are predisposed to new-onset diabetes after transplantation (often referred to as NODAT). Medications that promote development of NODAT include glucocorticoids, tacrolimus, and the mammalian target of rapamycin (mTOR) inhibitors sirolimus and everolimus.
If you want to change selection, open document below and click on "Move attachment"


owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p3418


statusnot read reprioritisations
last reprioritisation on suggested re-reading day
started reading on finished reading on



Do you want to join discussion? Click here to log in or create user.